Vimarsana
Biggest News Aggregation in the World

Concept Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Concept Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Concept Life Sciences Today - Breaking & Trending Today

Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities - Vimarsana News

Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities

Asymchem Laboratories Co., Ltd. announced today that it will operate the former Pfizer U.K. small molecule API pilot plant and part of the development laboratories through a new lease agreement...

Asymchem Laboratories (Tianjin) Co., Ltd.: Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities - Vimarsana News

Asymchem Laboratories (Tianjin) Co., Ltd.: Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities

Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it will operate the former Pfizer U.K. small molecule API pilot plant and part of the development laboratories

Transfer to maximise synergies and sharpen focus on growth - Vimarsana News

Transfer to maximise synergies and sharpen focus on growth

Concept Life Sciences a leading drug discovery, development and manufacturing organisation has carved out its Bradford analytical chemistry business to Cormica, a specialist in testing services for medical device and pharmaceutical manufacturers. Click to read more...

SelectScience Biopharma Summit 2023: Full meeting agenda - Vimarsana News

SelectScience Biopharma Summit 2023: Full meeting agenda

Explore the latest developments in biopharma with fellow scientists, manufacturers, and regulatory experts

hiPSC-derived microglia in modeling neurological diseases - Vimarsana News

hiPSC-derived microglia in modeling neurological diseases

How a leading contract research organization is utilizing hiPSC-derived microglia for neurodegenerative disease modeling